Search Results

Site Search

Five trends happening in the laboratory industry - Insights

Managing a successful hospital-based laboratory in today’s economic climate requires leaders to anticipate challenges, navigate obstacles, and develop creative approaches to unusual circumstances. The Mayo Clinic Laboratories outreach team...

Testing Archives - Page 19 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Stimulants - Insights

Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.

Drug class testing - Insights

Check out Mayo Clinic Laboratories’ full menu of testing for individual drug classes, including benzodiazepines, stimulants, opioids, alcohol, and more.

Testing Archives - Page 22 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 17 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 18 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Is the term "outreach" obsolete? - Insights

In a competitive outpatient testing market, choosing a laboratory is discretionary. With the goal of becoming the laboratory of choice for discretionary outpatient testing, it no longer matters if it is called “inreach” or “outreach.” While...

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. - Insights

Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal...

5 Steps to Improve Communication in Laboratory Outreach - Insights

Communication is a critical component of success. Laboratory outreach leaders can foster truly effective communication with five simple steps.